218 related articles for article (PubMed ID: 22434697)
1. Tumor response assessments with diffusion and perfusion MRI.
Li SP; Padhani AR
J Magn Reson Imaging; 2012 Apr; 35(4):745-63. PubMed ID: 22434697
[TBL] [Abstract][Full Text] [Related]
2. CT and MRI in monitoring response: state-of-the-art and future developments.
D'Ippolito G; Torres LR; Saito Filho CF; Ferreira RM
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):603-19. PubMed ID: 22231581
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
Afaq A; Koh DM; Padhani A; van As N; Sohaib SA
BJU Int; 2011 Dec; 108(11):1716-22. PubMed ID: 21631696
[TBL] [Abstract][Full Text] [Related]
4. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
5. Diffusion MR imaging for monitoring of treatment response.
Padhani AR; Koh DM
Magn Reson Imaging Clin N Am; 2011 Feb; 19(1):181-209. PubMed ID: 21129641
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance perfusion and permeability imaging in brain tumors.
Lacerda S; Law M
Neuroimaging Clin N Am; 2009 Nov; 19(4):527-57. PubMed ID: 19959004
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
8. Diffusion magnetic resonance imaging in cancer patient management.
Padhani AR
Semin Radiat Oncol; 2011 Apr; 21(2):119-40. PubMed ID: 21356480
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
10. Response assessment in oncology: limitations of anatomic response criteria in the era of tailored treatments.
Carnaghi C; Sclafani F; Basilico V; Doherty M
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):589-602. PubMed ID: 22231580
[TBL] [Abstract][Full Text] [Related]
11. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
12. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
[TBL] [Abstract][Full Text] [Related]
13. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
14. Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma.
Wang H; Zhang X; Ye H
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1017-22. PubMed ID: 21806325
[TBL] [Abstract][Full Text] [Related]
15. Role of diffusion and perfusion MRI in selecting patients for reperfusion therapies.
Grigoryan M; Tung CE; Albers GW
Neuroimaging Clin N Am; 2011 May; 21(2):247-57, ix-x. PubMed ID: 21640298
[TBL] [Abstract][Full Text] [Related]
16. Diffusion and perfusion MR imaging of the prostate.
Somford DM; Fütterer JJ; Hambrock T; Barentsz JO
Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):685-95, ix. PubMed ID: 18926431
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Musculoskeletal Malignancies with Functional MR Imaging.
Vilanova JC; Baleato-Gonzalez S; Romero MJ; Carrascoso-Arranz J; Luna A
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):239-259. PubMed ID: 26613884
[TBL] [Abstract][Full Text] [Related]
18. Hepatic tumor response evaluation by MRI.
Lee CH; Braga L; de Campos RO; Semelka RC
NMR Biomed; 2011 Jul; 24(6):721-33. PubMed ID: 21793076
[TBL] [Abstract][Full Text] [Related]
19. Diffusion and perfusion imaging of the liver.
Chandarana H; Taouli B
Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054
[TBL] [Abstract][Full Text] [Related]
20. Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.
Patterson DM; Padhani AR; Collins DJ
Nat Clin Pract Oncol; 2008 Apr; 5(4):220-33. PubMed ID: 18301415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
